Global EGFR-TKI Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global EGFR-TKI market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitors) are a class of targeted therapies designed to treat cancers driven by mutations in the EGFR gene, particularly non-small cell lung cancer (NSCLC).These drugs work by specifically inhibiting the tyrosine kinase activity of the EGFR.
This report is a detailed and comprehensive analysis for global EGFR-TKI market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Global EGFR-TKI market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global EGFR-TKI market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global EGFR-TKI market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Chapter 2, to profile the top manufacturers of EGFR-TKI, with price, sales quantity, revenue, and global market share of EGFR-TKI from 2021 to 2026.
Chapter 3, the EGFR-TKI competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the EGFR-TKI breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and EGFR-TKI market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of EGFR-TKI.
Chapter 14 and 15, to describe EGFR-TKI sales channel, distributors, customers, research findings and conclusion.
EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitors) are a class of targeted therapies designed to treat cancers driven by mutations in the EGFR gene, particularly non-small cell lung cancer (NSCLC).These drugs work by specifically inhibiting the tyrosine kinase activity of the EGFR.
This report is a detailed and comprehensive analysis for global EGFR-TKI market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global EGFR-TKI market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032Global EGFR-TKI market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global EGFR-TKI market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global EGFR-TKI market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for EGFR-TKI
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
EGFR-TKI market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Gefitinib
- Erlotinib
- Icotinib
- Afatinib
- Dacomitinib
- Osimertinib
- Aumolertinib
- Furmonertinib
- Lazertinib
- Other
Market segment by Application
- Hospital and Clinic
- Retail Pharmacies
- Other
Major players covered
- AstraZeneca
- Roche
- Betta Pharma
- Boehringer Ingelheim Pharmaceuticals
- Pfizer
- Chengdu Brilliant Pharmaceuticals
- Hansoh Pharma
- ArriVent Biopharma
- Hanmi Pharmaceutical
- Johnson & Johnson
- Yuhan Corporation
- Shanghai Allist Pharmaceuticals
- Wanbang Biopharmaceuticals
- Beacon Pharma
- Drug International
- Teva
- Mylan
- Glenmark Pharmaceuticals
- Cipla
Market segment by region, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe EGFR-TKI product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top manufacturers of EGFR-TKI, with price, sales quantity, revenue, and global market share of EGFR-TKI from 2021 to 2026.
Chapter 3, the EGFR-TKI competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the EGFR-TKI breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and EGFR-TKI market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of EGFR-TKI.
Chapter 14 and 15, to describe EGFR-TKI sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global EGFR-TKI Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Gefitinib
1.3.3 Erlotinib
1.3.4 Icotinib
1.3.5 Afatinib
1.3.6 Dacomitinib
1.3.7 Osimertinib
1.3.8 Aumolertinib
1.3.9 Furmonertinib
1.3.10 Lazertinib
1.4 Market Analysis by Application
1.4.1 Overview: Global EGFR-TKI Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital and Clinic
1.4.3 Retail Pharmacies
1.4.4 Other
1.5 Global EGFR-TKI Market Size & Forecast
1.5.1 Global EGFR-TKI Consumption Value (2021 & 2025 & 2032)
1.5.2 Global EGFR-TKI Sales Quantity (2021-2032)
1.5.3 Global EGFR-TKI Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca EGFR-TKI Product and Services
2.1.4 AstraZeneca EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche EGFR-TKI Product and Services
2.2.4 Roche EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Roche Recent Developments/Updates
2.3 Betta Pharma
2.3.1 Betta Pharma Details
2.3.2 Betta Pharma Major Business
2.3.3 Betta Pharma EGFR-TKI Product and Services
2.3.4 Betta Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Betta Pharma Recent Developments/Updates
2.4 Boehringer Ingelheim Pharmaceuticals
2.4.1 Boehringer Ingelheim Pharmaceuticals Details
2.4.2 Boehringer Ingelheim Pharmaceuticals Major Business
2.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product and Services
2.4.4 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer EGFR-TKI Product and Services
2.5.4 Pfizer EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Pfizer Recent Developments/Updates
2.6 Chengdu Brilliant Pharmaceuticals
2.6.1 Chengdu Brilliant Pharmaceuticals Details
2.6.2 Chengdu Brilliant Pharmaceuticals Major Business
2.6.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product and Services
2.6.4 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
2.7 Hansoh Pharma
2.7.1 Hansoh Pharma Details
2.7.2 Hansoh Pharma Major Business
2.7.3 Hansoh Pharma EGFR-TKI Product and Services
2.7.4 Hansoh Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Hansoh Pharma Recent Developments/Updates
2.8 ArriVent Biopharma
2.8.1 ArriVent Biopharma Details
2.8.2 ArriVent Biopharma Major Business
2.8.3 ArriVent Biopharma EGFR-TKI Product and Services
2.8.4 ArriVent Biopharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 ArriVent Biopharma Recent Developments/Updates
2.9 Hanmi Pharmaceutical
2.9.1 Hanmi Pharmaceutical Details
2.9.2 Hanmi Pharmaceutical Major Business
2.9.3 Hanmi Pharmaceutical EGFR-TKI Product and Services
2.9.4 Hanmi Pharmaceutical EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Hanmi Pharmaceutical Recent Developments/Updates
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson EGFR-TKI Product and Services
2.10.4 Johnson & Johnson EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Johnson & Johnson Recent Developments/Updates
2.11 Yuhan Corporation
2.11.1 Yuhan Corporation Details
2.11.2 Yuhan Corporation Major Business
2.11.3 Yuhan Corporation EGFR-TKI Product and Services
2.11.4 Yuhan Corporation EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Yuhan Corporation Recent Developments/Updates
2.12 Shanghai Allist Pharmaceuticals
2.12.1 Shanghai Allist Pharmaceuticals Details
2.12.2 Shanghai Allist Pharmaceuticals Major Business
2.12.3 Shanghai Allist Pharmaceuticals EGFR-TKI Product and Services
2.12.4 Shanghai Allist Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
2.13 Wanbang Biopharmaceuticals
2.13.1 Wanbang Biopharmaceuticals Details
2.13.2 Wanbang Biopharmaceuticals Major Business
2.13.3 Wanbang Biopharmaceuticals EGFR-TKI Product and Services
2.13.4 Wanbang Biopharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Wanbang Biopharmaceuticals Recent Developments/Updates
2.14 Beacon Pharma
2.14.1 Beacon Pharma Details
2.14.2 Beacon Pharma Major Business
2.14.3 Beacon Pharma EGFR-TKI Product and Services
2.14.4 Beacon Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Beacon Pharma Recent Developments/Updates
2.15 Drug International
2.15.1 Drug International Details
2.15.2 Drug International Major Business
2.15.3 Drug International EGFR-TKI Product and Services
2.15.4 Drug International EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Drug International Recent Developments/Updates
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business
2.16.3 Teva EGFR-TKI Product and Services
2.16.4 Teva EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Teva Recent Developments/Updates
2.17 Mylan
2.17.1 Mylan Details
2.17.2 Mylan Major Business
2.17.3 Mylan EGFR-TKI Product and Services
2.17.4 Mylan EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Mylan Recent Developments/Updates
2.18 Glenmark Pharmaceuticals
2.18.1 Glenmark Pharmaceuticals Details
2.18.2 Glenmark Pharmaceuticals Major Business
2.18.3 Glenmark Pharmaceuticals EGFR-TKI Product and Services
2.18.4 Glenmark Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Glenmark Pharmaceuticals Recent Developments/Updates
2.19 Cipla
2.19.1 Cipla Details
2.19.2 Cipla Major Business
2.19.3 Cipla EGFR-TKI Product and Services
2.19.4 Cipla EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Cipla Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EGFR-TKI BY MANUFACTURER
3.1 Global EGFR-TKI Sales Quantity by Manufacturer (2021-2026)
3.2 Global EGFR-TKI Revenue by Manufacturer (2021-2026)
3.3 Global EGFR-TKI Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of EGFR-TKI by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 EGFR-TKI Manufacturer Market Share in 2025
3.4.3 Top 6 EGFR-TKI Manufacturer Market Share in 2025
3.5 EGFR-TKI Market: Overall Company Footprint Analysis
3.5.1 EGFR-TKI Market: Region Footprint
3.5.2 EGFR-TKI Market: Company Product Type Footprint
3.5.3 EGFR-TKI Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global EGFR-TKI Market Size by Region
4.1.1 Global EGFR-TKI Sales Quantity by Region (2021-2032)
4.1.2 Global EGFR-TKI Consumption Value by Region (2021-2032)
4.1.3 Global EGFR-TKI Average Price by Region (2021-2032)
4.2 North America EGFR-TKI Consumption Value (2021-2032)
4.3 Europe EGFR-TKI Consumption Value (2021-2032)
4.4 Asia-Pacific EGFR-TKI Consumption Value (2021-2032)
4.5 South America EGFR-TKI Consumption Value (2021-2032)
4.6 Middle East & Africa EGFR-TKI Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global EGFR-TKI Sales Quantity by Type (2021-2032)
5.2 Global EGFR-TKI Consumption Value by Type (2021-2032)
5.3 Global EGFR-TKI Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global EGFR-TKI Sales Quantity by Application (2021-2032)
6.2 Global EGFR-TKI Consumption Value by Application (2021-2032)
6.3 Global EGFR-TKI Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America EGFR-TKI Sales Quantity by Type (2021-2032)
7.2 North America EGFR-TKI Sales Quantity by Application (2021-2032)
7.3 North America EGFR-TKI Market Size by Country
7.3.1 North America EGFR-TKI Sales Quantity by Country (2021-2032)
7.3.2 North America EGFR-TKI Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe EGFR-TKI Sales Quantity by Type (2021-2032)
8.2 Europe EGFR-TKI Sales Quantity by Application (2021-2032)
8.3 Europe EGFR-TKI Market Size by Country
8.3.1 Europe EGFR-TKI Sales Quantity by Country (2021-2032)
8.3.2 Europe EGFR-TKI Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific EGFR-TKI Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific EGFR-TKI Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific EGFR-TKI Market Size by Region
9.3.1 Asia-Pacific EGFR-TKI Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific EGFR-TKI Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America EGFR-TKI Sales Quantity by Type (2021-2032)
10.2 South America EGFR-TKI Sales Quantity by Application (2021-2032)
10.3 South America EGFR-TKI Market Size by Country
10.3.1 South America EGFR-TKI Sales Quantity by Country (2021-2032)
10.3.2 South America EGFR-TKI Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa EGFR-TKI Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa EGFR-TKI Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa EGFR-TKI Market Size by Country
11.3.1 Middle East & Africa EGFR-TKI Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa EGFR-TKI Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 EGFR-TKI Market Drivers
12.2 EGFR-TKI Market Restraints
12.3 EGFR-TKI Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of EGFR-TKI and Key Manufacturers
13.2 Manufacturing Costs Percentage of EGFR-TKI
13.3 EGFR-TKI Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 EGFR-TKI Typical Distributors
14.3 EGFR-TKI Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global EGFR-TKI Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Gefitinib
1.3.3 Erlotinib
1.3.4 Icotinib
1.3.5 Afatinib
1.3.6 Dacomitinib
1.3.7 Osimertinib
1.3.8 Aumolertinib
1.3.9 Furmonertinib
1.3.10 Lazertinib
1.4 Market Analysis by Application
1.4.1 Overview: Global EGFR-TKI Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital and Clinic
1.4.3 Retail Pharmacies
1.4.4 Other
1.5 Global EGFR-TKI Market Size & Forecast
1.5.1 Global EGFR-TKI Consumption Value (2021 & 2025 & 2032)
1.5.2 Global EGFR-TKI Sales Quantity (2021-2032)
1.5.3 Global EGFR-TKI Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca EGFR-TKI Product and Services
2.1.4 AstraZeneca EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche EGFR-TKI Product and Services
2.2.4 Roche EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Roche Recent Developments/Updates
2.3 Betta Pharma
2.3.1 Betta Pharma Details
2.3.2 Betta Pharma Major Business
2.3.3 Betta Pharma EGFR-TKI Product and Services
2.3.4 Betta Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Betta Pharma Recent Developments/Updates
2.4 Boehringer Ingelheim Pharmaceuticals
2.4.1 Boehringer Ingelheim Pharmaceuticals Details
2.4.2 Boehringer Ingelheim Pharmaceuticals Major Business
2.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product and Services
2.4.4 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer EGFR-TKI Product and Services
2.5.4 Pfizer EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Pfizer Recent Developments/Updates
2.6 Chengdu Brilliant Pharmaceuticals
2.6.1 Chengdu Brilliant Pharmaceuticals Details
2.6.2 Chengdu Brilliant Pharmaceuticals Major Business
2.6.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product and Services
2.6.4 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
2.7 Hansoh Pharma
2.7.1 Hansoh Pharma Details
2.7.2 Hansoh Pharma Major Business
2.7.3 Hansoh Pharma EGFR-TKI Product and Services
2.7.4 Hansoh Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Hansoh Pharma Recent Developments/Updates
2.8 ArriVent Biopharma
2.8.1 ArriVent Biopharma Details
2.8.2 ArriVent Biopharma Major Business
2.8.3 ArriVent Biopharma EGFR-TKI Product and Services
2.8.4 ArriVent Biopharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 ArriVent Biopharma Recent Developments/Updates
2.9 Hanmi Pharmaceutical
2.9.1 Hanmi Pharmaceutical Details
2.9.2 Hanmi Pharmaceutical Major Business
2.9.3 Hanmi Pharmaceutical EGFR-TKI Product and Services
2.9.4 Hanmi Pharmaceutical EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Hanmi Pharmaceutical Recent Developments/Updates
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson EGFR-TKI Product and Services
2.10.4 Johnson & Johnson EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Johnson & Johnson Recent Developments/Updates
2.11 Yuhan Corporation
2.11.1 Yuhan Corporation Details
2.11.2 Yuhan Corporation Major Business
2.11.3 Yuhan Corporation EGFR-TKI Product and Services
2.11.4 Yuhan Corporation EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Yuhan Corporation Recent Developments/Updates
2.12 Shanghai Allist Pharmaceuticals
2.12.1 Shanghai Allist Pharmaceuticals Details
2.12.2 Shanghai Allist Pharmaceuticals Major Business
2.12.3 Shanghai Allist Pharmaceuticals EGFR-TKI Product and Services
2.12.4 Shanghai Allist Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
2.13 Wanbang Biopharmaceuticals
2.13.1 Wanbang Biopharmaceuticals Details
2.13.2 Wanbang Biopharmaceuticals Major Business
2.13.3 Wanbang Biopharmaceuticals EGFR-TKI Product and Services
2.13.4 Wanbang Biopharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Wanbang Biopharmaceuticals Recent Developments/Updates
2.14 Beacon Pharma
2.14.1 Beacon Pharma Details
2.14.2 Beacon Pharma Major Business
2.14.3 Beacon Pharma EGFR-TKI Product and Services
2.14.4 Beacon Pharma EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Beacon Pharma Recent Developments/Updates
2.15 Drug International
2.15.1 Drug International Details
2.15.2 Drug International Major Business
2.15.3 Drug International EGFR-TKI Product and Services
2.15.4 Drug International EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Drug International Recent Developments/Updates
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business
2.16.3 Teva EGFR-TKI Product and Services
2.16.4 Teva EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Teva Recent Developments/Updates
2.17 Mylan
2.17.1 Mylan Details
2.17.2 Mylan Major Business
2.17.3 Mylan EGFR-TKI Product and Services
2.17.4 Mylan EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Mylan Recent Developments/Updates
2.18 Glenmark Pharmaceuticals
2.18.1 Glenmark Pharmaceuticals Details
2.18.2 Glenmark Pharmaceuticals Major Business
2.18.3 Glenmark Pharmaceuticals EGFR-TKI Product and Services
2.18.4 Glenmark Pharmaceuticals EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Glenmark Pharmaceuticals Recent Developments/Updates
2.19 Cipla
2.19.1 Cipla Details
2.19.2 Cipla Major Business
2.19.3 Cipla EGFR-TKI Product and Services
2.19.4 Cipla EGFR-TKI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Cipla Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: EGFR-TKI BY MANUFACTURER
3.1 Global EGFR-TKI Sales Quantity by Manufacturer (2021-2026)
3.2 Global EGFR-TKI Revenue by Manufacturer (2021-2026)
3.3 Global EGFR-TKI Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of EGFR-TKI by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 EGFR-TKI Manufacturer Market Share in 2025
3.4.3 Top 6 EGFR-TKI Manufacturer Market Share in 2025
3.5 EGFR-TKI Market: Overall Company Footprint Analysis
3.5.1 EGFR-TKI Market: Region Footprint
3.5.2 EGFR-TKI Market: Company Product Type Footprint
3.5.3 EGFR-TKI Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global EGFR-TKI Market Size by Region
4.1.1 Global EGFR-TKI Sales Quantity by Region (2021-2032)
4.1.2 Global EGFR-TKI Consumption Value by Region (2021-2032)
4.1.3 Global EGFR-TKI Average Price by Region (2021-2032)
4.2 North America EGFR-TKI Consumption Value (2021-2032)
4.3 Europe EGFR-TKI Consumption Value (2021-2032)
4.4 Asia-Pacific EGFR-TKI Consumption Value (2021-2032)
4.5 South America EGFR-TKI Consumption Value (2021-2032)
4.6 Middle East & Africa EGFR-TKI Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global EGFR-TKI Sales Quantity by Type (2021-2032)
5.2 Global EGFR-TKI Consumption Value by Type (2021-2032)
5.3 Global EGFR-TKI Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global EGFR-TKI Sales Quantity by Application (2021-2032)
6.2 Global EGFR-TKI Consumption Value by Application (2021-2032)
6.3 Global EGFR-TKI Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America EGFR-TKI Sales Quantity by Type (2021-2032)
7.2 North America EGFR-TKI Sales Quantity by Application (2021-2032)
7.3 North America EGFR-TKI Market Size by Country
7.3.1 North America EGFR-TKI Sales Quantity by Country (2021-2032)
7.3.2 North America EGFR-TKI Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe EGFR-TKI Sales Quantity by Type (2021-2032)
8.2 Europe EGFR-TKI Sales Quantity by Application (2021-2032)
8.3 Europe EGFR-TKI Market Size by Country
8.3.1 Europe EGFR-TKI Sales Quantity by Country (2021-2032)
8.3.2 Europe EGFR-TKI Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific EGFR-TKI Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific EGFR-TKI Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific EGFR-TKI Market Size by Region
9.3.1 Asia-Pacific EGFR-TKI Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific EGFR-TKI Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America EGFR-TKI Sales Quantity by Type (2021-2032)
10.2 South America EGFR-TKI Sales Quantity by Application (2021-2032)
10.3 South America EGFR-TKI Market Size by Country
10.3.1 South America EGFR-TKI Sales Quantity by Country (2021-2032)
10.3.2 South America EGFR-TKI Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa EGFR-TKI Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa EGFR-TKI Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa EGFR-TKI Market Size by Country
11.3.1 Middle East & Africa EGFR-TKI Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa EGFR-TKI Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 EGFR-TKI Market Drivers
12.2 EGFR-TKI Market Restraints
12.3 EGFR-TKI Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of EGFR-TKI and Key Manufacturers
13.2 Manufacturing Costs Percentage of EGFR-TKI
13.3 EGFR-TKI Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 EGFR-TKI Typical Distributors
14.3 EGFR-TKI Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global EGFR-TKI Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global EGFR-TKI Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca EGFR-TKI Product and Services
Table 6. AstraZeneca EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Roche Basic Information, Manufacturing Base and Competitors
Table 9. Roche Major Business
Table 10. Roche EGFR-TKI Product and Services
Table 11. Roche EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Roche Recent Developments/Updates
Table 13. Betta Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Betta Pharma Major Business
Table 15. Betta Pharma EGFR-TKI Product and Services
Table 16. Betta Pharma EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Betta Pharma Recent Developments/Updates
Table 18. Boehringer Ingelheim Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Boehringer Ingelheim Pharmaceuticals Major Business
Table 20. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product and Services
Table 21. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer EGFR-TKI Product and Services
Table 26. Pfizer EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Pfizer Recent Developments/Updates
Table 28. Chengdu Brilliant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Chengdu Brilliant Pharmaceuticals Major Business
Table 30. Chengdu Brilliant Pharmaceuticals EGFR-TKI Product and Services
Table 31. Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
Table 33. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Hansoh Pharma Major Business
Table 35. Hansoh Pharma EGFR-TKI Product and Services
Table 36. Hansoh Pharma EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Hansoh Pharma Recent Developments/Updates
Table 38. ArriVent Biopharma Basic Information, Manufacturing Base and Competitors
Table 39. ArriVent Biopharma Major Business
Table 40. ArriVent Biopharma EGFR-TKI Product and Services
Table 41. ArriVent Biopharma EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. ArriVent Biopharma Recent Developments/Updates
Table 43. Hanmi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Hanmi Pharmaceutical Major Business
Table 45. Hanmi Pharmaceutical EGFR-TKI Product and Services
Table 46. Hanmi Pharmaceutical EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Hanmi Pharmaceutical Recent Developments/Updates
Table 48. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Major Business
Table 50. Johnson & Johnson EGFR-TKI Product and Services
Table 51. Johnson & Johnson EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. Yuhan Corporation Basic Information, Manufacturing Base and Competitors
Table 54. Yuhan Corporation Major Business
Table 55. Yuhan Corporation EGFR-TKI Product and Services
Table 56. Yuhan Corporation EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Yuhan Corporation Recent Developments/Updates
Table 58. Shanghai Allist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Shanghai Allist Pharmaceuticals Major Business
Table 60. Shanghai Allist Pharmaceuticals EGFR-TKI Product and Services
Table 61. Shanghai Allist Pharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 63. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Wanbang Biopharmaceuticals Major Business
Table 65. Wanbang Biopharmaceuticals EGFR-TKI Product and Services
Table 66. Wanbang Biopharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 68. Beacon Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Beacon Pharma Major Business
Table 70. Beacon Pharma EGFR-TKI Product and Services
Table 71. Beacon Pharma EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Beacon Pharma Recent Developments/Updates
Table 73. Drug International Basic Information, Manufacturing Base and Competitors
Table 74. Drug International Major Business
Table 75. Drug International EGFR-TKI Product and Services
Table 76. Drug International EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Drug International Recent Developments/Updates
Table 78. Teva Basic Information, Manufacturing Base and Competitors
Table 79. Teva Major Business
Table 80. Teva EGFR-TKI Product and Services
Table 81. Teva EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Teva Recent Developments/Updates
Table 83. Mylan Basic Information, Manufacturing Base and Competitors
Table 84. Mylan Major Business
Table 85. Mylan EGFR-TKI Product and Services
Table 86. Mylan EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Mylan Recent Developments/Updates
Table 88. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 89. Glenmark Pharmaceuticals Major Business
Table 90. Glenmark Pharmaceuticals EGFR-TKI Product and Services
Table 91. Glenmark Pharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Glenmark Pharmaceuticals Recent Developments/Updates
Table 93. Cipla Basic Information, Manufacturing Base and Competitors
Table 94. Cipla Major Business
Table 95. Cipla EGFR-TKI Product and Services
Table 96. Cipla EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Cipla Recent Developments/Updates
Table 98. Global EGFR-TKI Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 99. Global EGFR-TKI Revenue by Manufacturer (2021-2026) & (USD Million)
Table 100. Global EGFR-TKI Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 101. Market Position of Manufacturers in EGFR-TKI, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 102. Head Office and EGFR-TKI Production Site of Key Manufacturer
Table 103. EGFR-TKI Market: Company Product Type Footprint
Table 104. EGFR-TKI Market: Company Product Application Footprint
Table 105. EGFR-TKI New Market Entrants and Barriers to Market Entry
Table 106. EGFR-TKI Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global EGFR-TKI Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 108. Global EGFR-TKI Sales Quantity by Region (2021-2026) & (K Units)
Table 109. Global EGFR-TKI Sales Quantity by Region (2027-2032) & (K Units)
Table 110. Global EGFR-TKI Consumption Value by Region (2021-2026) & (USD Million)
Table 111. Global EGFR-TKI Consumption Value by Region (2027-2032) & (USD Million)
Table 112. Global EGFR-TKI Average Price by Region (2021-2026) & (US$/Unit)
Table 113. Global EGFR-TKI Average Price by Region (2027-2032) & (US$/Unit)
Table 114. Global EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 115. Global EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 116. Global EGFR-TKI Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Global EGFR-TKI Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Global EGFR-TKI Average Price by Type (2021-2026) & (US$/Unit)
Table 119. Global EGFR-TKI Average Price by Type (2027-2032) & (US$/Unit)
Table 120. Global EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 121. Global EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 122. Global EGFR-TKI Consumption Value by Application (2021-2026) & (USD Million)
Table 123. Global EGFR-TKI Consumption Value by Application (2027-2032) & (USD Million)
Table 124. Global EGFR-TKI Average Price by Application (2021-2026) & (US$/Unit)
Table 125. Global EGFR-TKI Average Price by Application (2027-2032) & (US$/Unit)
Table 126. North America EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 127. North America EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 128. North America EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 129. North America EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 130. North America EGFR-TKI Sales Quantity by Country (2021-2026) & (K Units)
Table 131. North America EGFR-TKI Sales Quantity by Country (2027-2032) & (K Units)
Table 132. North America EGFR-TKI Consumption Value by Country (2021-2026) & (USD Million)
Table 133. North America EGFR-TKI Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Europe EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 135. Europe EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 136. Europe EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 137. Europe EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 138. Europe EGFR-TKI Sales Quantity by Country (2021-2026) & (K Units)
Table 139. Europe EGFR-TKI Sales Quantity by Country (2027-2032) & (K Units)
Table 140. Europe EGFR-TKI Consumption Value by Country (2021-2026) & (USD Million)
Table 141. Europe EGFR-TKI Consumption Value by Country (2027-2032) & (USD Million)
Table 142. Asia-Pacific EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 143. Asia-Pacific EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 144. Asia-Pacific EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 145. Asia-Pacific EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 146. Asia-Pacific EGFR-TKI Sales Quantity by Region (2021-2026) & (K Units)
Table 147. Asia-Pacific EGFR-TKI Sales Quantity by Region (2027-2032) & (K Units)
Table 148. Asia-Pacific EGFR-TKI Consumption Value by Region (2021-2026) & (USD Million)
Table 149. Asia-Pacific EGFR-TKI Consumption Value by Region (2027-2032) & (USD Million)
Table 150. South America EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 151. South America EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 152. South America EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 153. South America EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 154. South America EGFR-TKI Sales Quantity by Country (2021-2026) & (K Units)
Table 155. South America EGFR-TKI Sales Quantity by Country (2027-2032) & (K Units)
Table 156. South America EGFR-TKI Consumption Value by Country (2021-2026) & (USD Million)
Table 157. South America EGFR-TKI Consumption Value by Country (2027-2032) & (USD Million)
Table 158. Middle East & Africa EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 159. Middle East & Africa EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 160. Middle East & Africa EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 161. Middle East & Africa EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 162. Middle East & Africa EGFR-TKI Sales Quantity by Country (2021-2026) & (K Units)
Table 163. Middle East & Africa EGFR-TKI Sales Quantity by Country (2027-2032) & (K Units)
Table 164. Middle East & Africa EGFR-TKI Consumption Value by Country (2021-2026) & (USD Million)
Table 165. Middle East & Africa EGFR-TKI Consumption Value by Country (2027-2032) & (USD Million)
Table 166. EGFR-TKI Raw Material
Table 167. Key Manufacturers of EGFR-TKI Raw Materials
Table 168. EGFR-TKI Typical Distributors
Table 169. EGFR-TKI Typical Customers
Table 1. Global EGFR-TKI Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global EGFR-TKI Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca EGFR-TKI Product and Services
Table 6. AstraZeneca EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Roche Basic Information, Manufacturing Base and Competitors
Table 9. Roche Major Business
Table 10. Roche EGFR-TKI Product and Services
Table 11. Roche EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Roche Recent Developments/Updates
Table 13. Betta Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Betta Pharma Major Business
Table 15. Betta Pharma EGFR-TKI Product and Services
Table 16. Betta Pharma EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Betta Pharma Recent Developments/Updates
Table 18. Boehringer Ingelheim Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Boehringer Ingelheim Pharmaceuticals Major Business
Table 20. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product and Services
Table 21. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Boehringer Ingelheim Pharmaceuticals Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer EGFR-TKI Product and Services
Table 26. Pfizer EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Pfizer Recent Developments/Updates
Table 28. Chengdu Brilliant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Chengdu Brilliant Pharmaceuticals Major Business
Table 30. Chengdu Brilliant Pharmaceuticals EGFR-TKI Product and Services
Table 31. Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Chengdu Brilliant Pharmaceuticals Recent Developments/Updates
Table 33. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Hansoh Pharma Major Business
Table 35. Hansoh Pharma EGFR-TKI Product and Services
Table 36. Hansoh Pharma EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Hansoh Pharma Recent Developments/Updates
Table 38. ArriVent Biopharma Basic Information, Manufacturing Base and Competitors
Table 39. ArriVent Biopharma Major Business
Table 40. ArriVent Biopharma EGFR-TKI Product and Services
Table 41. ArriVent Biopharma EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. ArriVent Biopharma Recent Developments/Updates
Table 43. Hanmi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Hanmi Pharmaceutical Major Business
Table 45. Hanmi Pharmaceutical EGFR-TKI Product and Services
Table 46. Hanmi Pharmaceutical EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. Hanmi Pharmaceutical Recent Developments/Updates
Table 48. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 49. Johnson & Johnson Major Business
Table 50. Johnson & Johnson EGFR-TKI Product and Services
Table 51. Johnson & Johnson EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Johnson & Johnson Recent Developments/Updates
Table 53. Yuhan Corporation Basic Information, Manufacturing Base and Competitors
Table 54. Yuhan Corporation Major Business
Table 55. Yuhan Corporation EGFR-TKI Product and Services
Table 56. Yuhan Corporation EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Yuhan Corporation Recent Developments/Updates
Table 58. Shanghai Allist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Shanghai Allist Pharmaceuticals Major Business
Table 60. Shanghai Allist Pharmaceuticals EGFR-TKI Product and Services
Table 61. Shanghai Allist Pharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 62. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 63. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Wanbang Biopharmaceuticals Major Business
Table 65. Wanbang Biopharmaceuticals EGFR-TKI Product and Services
Table 66. Wanbang Biopharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 67. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 68. Beacon Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Beacon Pharma Major Business
Table 70. Beacon Pharma EGFR-TKI Product and Services
Table 71. Beacon Pharma EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Beacon Pharma Recent Developments/Updates
Table 73. Drug International Basic Information, Manufacturing Base and Competitors
Table 74. Drug International Major Business
Table 75. Drug International EGFR-TKI Product and Services
Table 76. Drug International EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Drug International Recent Developments/Updates
Table 78. Teva Basic Information, Manufacturing Base and Competitors
Table 79. Teva Major Business
Table 80. Teva EGFR-TKI Product and Services
Table 81. Teva EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 82. Teva Recent Developments/Updates
Table 83. Mylan Basic Information, Manufacturing Base and Competitors
Table 84. Mylan Major Business
Table 85. Mylan EGFR-TKI Product and Services
Table 86. Mylan EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 87. Mylan Recent Developments/Updates
Table 88. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 89. Glenmark Pharmaceuticals Major Business
Table 90. Glenmark Pharmaceuticals EGFR-TKI Product and Services
Table 91. Glenmark Pharmaceuticals EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Glenmark Pharmaceuticals Recent Developments/Updates
Table 93. Cipla Basic Information, Manufacturing Base and Competitors
Table 94. Cipla Major Business
Table 95. Cipla EGFR-TKI Product and Services
Table 96. Cipla EGFR-TKI Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Cipla Recent Developments/Updates
Table 98. Global EGFR-TKI Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 99. Global EGFR-TKI Revenue by Manufacturer (2021-2026) & (USD Million)
Table 100. Global EGFR-TKI Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 101. Market Position of Manufacturers in EGFR-TKI, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 102. Head Office and EGFR-TKI Production Site of Key Manufacturer
Table 103. EGFR-TKI Market: Company Product Type Footprint
Table 104. EGFR-TKI Market: Company Product Application Footprint
Table 105. EGFR-TKI New Market Entrants and Barriers to Market Entry
Table 106. EGFR-TKI Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global EGFR-TKI Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 108. Global EGFR-TKI Sales Quantity by Region (2021-2026) & (K Units)
Table 109. Global EGFR-TKI Sales Quantity by Region (2027-2032) & (K Units)
Table 110. Global EGFR-TKI Consumption Value by Region (2021-2026) & (USD Million)
Table 111. Global EGFR-TKI Consumption Value by Region (2027-2032) & (USD Million)
Table 112. Global EGFR-TKI Average Price by Region (2021-2026) & (US$/Unit)
Table 113. Global EGFR-TKI Average Price by Region (2027-2032) & (US$/Unit)
Table 114. Global EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 115. Global EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 116. Global EGFR-TKI Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Global EGFR-TKI Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Global EGFR-TKI Average Price by Type (2021-2026) & (US$/Unit)
Table 119. Global EGFR-TKI Average Price by Type (2027-2032) & (US$/Unit)
Table 120. Global EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 121. Global EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 122. Global EGFR-TKI Consumption Value by Application (2021-2026) & (USD Million)
Table 123. Global EGFR-TKI Consumption Value by Application (2027-2032) & (USD Million)
Table 124. Global EGFR-TKI Average Price by Application (2021-2026) & (US$/Unit)
Table 125. Global EGFR-TKI Average Price by Application (2027-2032) & (US$/Unit)
Table 126. North America EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 127. North America EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 128. North America EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 129. North America EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 130. North America EGFR-TKI Sales Quantity by Country (2021-2026) & (K Units)
Table 131. North America EGFR-TKI Sales Quantity by Country (2027-2032) & (K Units)
Table 132. North America EGFR-TKI Consumption Value by Country (2021-2026) & (USD Million)
Table 133. North America EGFR-TKI Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Europe EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 135. Europe EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 136. Europe EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 137. Europe EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 138. Europe EGFR-TKI Sales Quantity by Country (2021-2026) & (K Units)
Table 139. Europe EGFR-TKI Sales Quantity by Country (2027-2032) & (K Units)
Table 140. Europe EGFR-TKI Consumption Value by Country (2021-2026) & (USD Million)
Table 141. Europe EGFR-TKI Consumption Value by Country (2027-2032) & (USD Million)
Table 142. Asia-Pacific EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 143. Asia-Pacific EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 144. Asia-Pacific EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 145. Asia-Pacific EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 146. Asia-Pacific EGFR-TKI Sales Quantity by Region (2021-2026) & (K Units)
Table 147. Asia-Pacific EGFR-TKI Sales Quantity by Region (2027-2032) & (K Units)
Table 148. Asia-Pacific EGFR-TKI Consumption Value by Region (2021-2026) & (USD Million)
Table 149. Asia-Pacific EGFR-TKI Consumption Value by Region (2027-2032) & (USD Million)
Table 150. South America EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 151. South America EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 152. South America EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 153. South America EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 154. South America EGFR-TKI Sales Quantity by Country (2021-2026) & (K Units)
Table 155. South America EGFR-TKI Sales Quantity by Country (2027-2032) & (K Units)
Table 156. South America EGFR-TKI Consumption Value by Country (2021-2026) & (USD Million)
Table 157. South America EGFR-TKI Consumption Value by Country (2027-2032) & (USD Million)
Table 158. Middle East & Africa EGFR-TKI Sales Quantity by Type (2021-2026) & (K Units)
Table 159. Middle East & Africa EGFR-TKI Sales Quantity by Type (2027-2032) & (K Units)
Table 160. Middle East & Africa EGFR-TKI Sales Quantity by Application (2021-2026) & (K Units)
Table 161. Middle East & Africa EGFR-TKI Sales Quantity by Application (2027-2032) & (K Units)
Table 162. Middle East & Africa EGFR-TKI Sales Quantity by Country (2021-2026) & (K Units)
Table 163. Middle East & Africa EGFR-TKI Sales Quantity by Country (2027-2032) & (K Units)
Table 164. Middle East & Africa EGFR-TKI Consumption Value by Country (2021-2026) & (USD Million)
Table 165. Middle East & Africa EGFR-TKI Consumption Value by Country (2027-2032) & (USD Million)
Table 166. EGFR-TKI Raw Material
Table 167. Key Manufacturers of EGFR-TKI Raw Materials
Table 168. EGFR-TKI Typical Distributors
Table 169. EGFR-TKI Typical Customers
LIST OF FIGURES
Figure 1. EGFR-TKI Picture
Figure 2. Global EGFR-TKI Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global EGFR-TKI Revenue Market Share by Type in 2025
Figure 4. Gefitinib Examples
Figure 5. Erlotinib Examples
Figure 6. Icotinib Examples
Figure 7. Afatinib Examples
Figure 8. Dacomitinib Examples
Figure 9. Osimertinib Examples
Figure 10. Aumolertinib Examples
Figure 11. Furmonertinib Examples
Figure 12. Aumolertinib Examples
Figure 13. Global EGFR-TKI Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global EGFR-TKI Revenue Market Share by Application in 2025
Figure 15. Hospital and Clinic Examples
Figure 16. Retail Pharmacies Examples
Figure 17. Other Examples
Figure 18. Global EGFR-TKI Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global EGFR-TKI Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global EGFR-TKI Sales Quantity (2021-2032) & (K Units)
Figure 21. Global EGFR-TKI Price (2021-2032) & (US$/Unit)
Figure 22. Global EGFR-TKI Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global EGFR-TKI Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of EGFR-TKI by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 EGFR-TKI Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 EGFR-TKI Manufacturer (Revenue) Market Share in 2025
Figure 27. Global EGFR-TKI Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global EGFR-TKI Consumption Value Market Share by Region (2021-2032)
Figure 29. North America EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 32. South America EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 34. Global EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global EGFR-TKI Consumption Value Market Share by Type (2021-2032)
Figure 36. Global EGFR-TKI Average Price by Type (2021-2032) & (US$/Unit)
Figure 37. Global EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global EGFR-TKI Revenue Market Share by Application (2021-2032)
Figure 39. Global EGFR-TKI Average Price by Application (2021-2032) & (US$/Unit)
Figure 40. North America EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America EGFR-TKI Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America EGFR-TKI Consumption Value Market Share by Country (2021-2032)
Figure 44. United States EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe EGFR-TKI Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe EGFR-TKI Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 52. France EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific EGFR-TKI Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific EGFR-TKI Consumption Value Market Share by Region (2021-2032)
Figure 60. China EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 63. India EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 66. South America EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America EGFR-TKI Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America EGFR-TKI Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa EGFR-TKI Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa EGFR-TKI Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 80. EGFR-TKI Market Drivers
Figure 81. EGFR-TKI Market Restraints
Figure 82. EGFR-TKI Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of EGFR-TKI in 2025
Figure 85. Manufacturing Process Analysis of EGFR-TKI
Figure 86. EGFR-TKI Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Figure 1. EGFR-TKI Picture
Figure 2. Global EGFR-TKI Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global EGFR-TKI Revenue Market Share by Type in 2025
Figure 4. Gefitinib Examples
Figure 5. Erlotinib Examples
Figure 6. Icotinib Examples
Figure 7. Afatinib Examples
Figure 8. Dacomitinib Examples
Figure 9. Osimertinib Examples
Figure 10. Aumolertinib Examples
Figure 11. Furmonertinib Examples
Figure 12. Aumolertinib Examples
Figure 13. Global EGFR-TKI Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Global EGFR-TKI Revenue Market Share by Application in 2025
Figure 15. Hospital and Clinic Examples
Figure 16. Retail Pharmacies Examples
Figure 17. Other Examples
Figure 18. Global EGFR-TKI Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global EGFR-TKI Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global EGFR-TKI Sales Quantity (2021-2032) & (K Units)
Figure 21. Global EGFR-TKI Price (2021-2032) & (US$/Unit)
Figure 22. Global EGFR-TKI Sales Quantity Market Share by Manufacturer in 2025
Figure 23. Global EGFR-TKI Revenue Market Share by Manufacturer in 2025
Figure 24. Producer Shipments of EGFR-TKI by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 25. Top 3 EGFR-TKI Manufacturer (Revenue) Market Share in 2025
Figure 26. Top 6 EGFR-TKI Manufacturer (Revenue) Market Share in 2025
Figure 27. Global EGFR-TKI Sales Quantity Market Share by Region (2021-2032)
Figure 28. Global EGFR-TKI Consumption Value Market Share by Region (2021-2032)
Figure 29. North America EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 32. South America EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 34. Global EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 35. Global EGFR-TKI Consumption Value Market Share by Type (2021-2032)
Figure 36. Global EGFR-TKI Average Price by Type (2021-2032) & (US$/Unit)
Figure 37. Global EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 38. Global EGFR-TKI Revenue Market Share by Application (2021-2032)
Figure 39. Global EGFR-TKI Average Price by Application (2021-2032) & (US$/Unit)
Figure 40. North America EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 41. North America EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 42. North America EGFR-TKI Sales Quantity Market Share by Country (2021-2032)
Figure 43. North America EGFR-TKI Consumption Value Market Share by Country (2021-2032)
Figure 44. United States EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 45. Canada EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 46. Mexico EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 47. Europe EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 48. Europe EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 49. Europe EGFR-TKI Sales Quantity Market Share by Country (2021-2032)
Figure 50. Europe EGFR-TKI Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 52. France EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 57. Asia-Pacific EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 58. Asia-Pacific EGFR-TKI Sales Quantity Market Share by Region (2021-2032)
Figure 59. Asia-Pacific EGFR-TKI Consumption Value Market Share by Region (2021-2032)
Figure 60. China EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 63. India EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 66. South America EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 67. South America EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 68. South America EGFR-TKI Sales Quantity Market Share by Country (2021-2032)
Figure 69. South America EGFR-TKI Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa EGFR-TKI Sales Quantity Market Share by Type (2021-2032)
Figure 73. Middle East & Africa EGFR-TKI Sales Quantity Market Share by Application (2021-2032)
Figure 74. Middle East & Africa EGFR-TKI Sales Quantity Market Share by Country (2021-2032)
Figure 75. Middle East & Africa EGFR-TKI Consumption Value Market Share by Country (2021-2032)
Figure 76. Turkey EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 77. Egypt EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 78. Saudi Arabia EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 79. South Africa EGFR-TKI Consumption Value (2021-2032) & (USD Million)
Figure 80. EGFR-TKI Market Drivers
Figure 81. EGFR-TKI Market Restraints
Figure 82. EGFR-TKI Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of EGFR-TKI in 2025
Figure 85. Manufacturing Process Analysis of EGFR-TKI
Figure 86. EGFR-TKI Industrial Chain
Figure 87. Sales Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
